Lupin launches generic Loteprednol Etabonate Ophthalmic Suspension in the US market, a bioequivalent to Lotemax, to treat eye ...

J&J reported second quarter earnings Tuesday. The company is under scrutiny by investors as it faces drug patent cliffs.

Biocon plans to launch generic copies of Wegovy in India and Canada within two years, targeting a growing drug market ...

Biocon is set to launch generic versions of Wegovy in India and Canada, aiming for market entry by late 2026 or early 2027.

A first of its kind website offering evidence-based psychological support for people with visible differences and their ...